Skip to content. | Skip to navigation

Personal tools

Sections
You are here: Home / Teams / Alternative splicing and tumoral progression - D. Auboeuf / Publications / ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin

ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin

I. Tanaka, A. Chakraborty, O. Saulnier, C. Benoit-Pilven, S. Vacher, D. Labiod, E. WF Lam, I. Bi?che, O. Delattre, F. Pouzoulet, D. Auboeuf, S. Vagner, and M. Dutertre (2020)

Nucleic Acids Res, 48(5):2676–2693.

Document Actions